NEWS and EVENTS
NOV / 2021
SYMYOO America, Inc. Established
Established Symyoo America, Inc. in order to provide global trial consulting services for the Korean pharmaceutical, biotechnology and life-science companies wishing to enter the global market.
NOV / 2019
CDISC/SDTM Industry Partner
Symyoo participated in Korea CDISC Coordinating Committee (K3C) and achived CDISC/SCDM industry partnership, which is granted to a company having comprehensive data management capability for clinical research.
MAR / 2019
IWRS, RBM Integration into SYMYOO EDC, SYNeRA™
Symyoo EDC system, SYNeRA™, expanded its functionalities by integrating new modules, including IWRS (Interactive Web-based Randomization System), IP Accountability (Investigational Product Tracking and Management System), and RBM (Risk-Based Monitoring System). Symyoo IWRS can handle various randomization algorithms from simple purmuted block randomization to very complex covariate adaptive randomization (biased coin, minimum sufficient).
NOV / 2018
150+ Trials and 30th Oncology Trial on SYMYOO's 9th Anniversary
Conducted more than 150 clinical studies, including 30 oncology trials over 9 years since Symyoo foundation in 2009.
FEB / 2016
Introducing SYMYOO EDC, SYNeRA™
Launched Symyoo EDC system, SYNeRA™ for clinical research data collection and management. Symyoo SMART TRIALS research center continues to develop and expand SYNeRA™ functionalities into a web-based Comprehensive Clinical Trial Management System.
OCT / 2015
Partnership with KU Anam Hospital
Began research collaboration with Global Clinical Trial Center of Anam Hospital, Korea University Medical Center
SEP / 2014
Korea CRO Association Member
Qualified for full membership in Korea Clinical Trial CRO Association.
JUL / 2014
SMART TRIALS Research Center
Established SMART TRIALS center to research and faciliate new IT technologies for tomorrow's medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
SEP / 2013
Partnership with Inje Clinical Trial Center
Partnership contract with Clinical Trial Center of Baek University Hospital, Inje University
NOV / 2012
First Global Phase III Trial as Coordinating Center
Symyoo was designated as the Korea coordinating center to run a multinational phase III clinical trial, which was the first NIH/NINDS study (ATACH 2: Antihypertensive Treatment of Acute Cerebral Hemorrhage II) operated in South Korea. The sponsor audit was also conducted to evaluate trial conduct and compliance with the protocol and SOPs without finding any issue when the trial was successfully completed in 2015.
MAR / 2010
First Phase III Pivotal Trial
Symyoo expanded its business into a full scope CRO and began to operate a first phase III trial for permature ejaculation study.
NOV / 2009
Dongjin Yoo, CEO & MD, founded a CRO to help K-Bio industry's clinical development after his successful journey as a CEO and medical director of many global pharmaceuticals and bio startups.